The significance of adnexal involvement in endometrial carcinoma

被引:58
作者
Connell, PP
Rotmensch, J
Waggoner, S
Mundt, AJ
机构
[1] Univ Chicago Hosp, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[2] Univ Chicago Hosp, Dept Obstet & Gynecol, Gynecol Oncol Sect, Chicago, IL 60637 USA
关键词
D O I
10.1006/gyno.1999.5415
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To evaluate the prognostic significance of and predictive factors for adnexal involvement (AI) in patients with endometrial carcinoma. Methods. We retrospectively reviewed the pathological features and outcomes of endometrial carcinoma patients. The prognostic significance of AI was examined by univariate and multivariate analyses. Median follow-up was 30.7 months. Results. Of the 382 cases reviewed, 40 (10.5%) had AI. Patients with AI had a worse 5-year disease-free (DFS) survival (73.1 vs 37.1%, P < 0.0001) than patients without AI, However, patients with AI had multiple adverse features, including high grade disease, lymphovascular invasion, and additional sites of extrauterine disease. After controlling for these factors on multivariate analysis, AI lost its prognostic significance (P = 0.56). The 12 AI patients without other extrauterine disease had a favorable outcome (5-year DFS of 70.9%), Factors predictive of AI on logistic regression were metastatic disease, positive peritoneal washings, cervical involvement, and unfavorable histology, Conclusion. Endometrial carcinoma patients with AI have relatively poor prognoses. However, AI per se has little, if any, independent prognostic significance. The poor outcomes seen in these patients appear to result from the preponderance of other adverse pathologic factors, (C) 1999 academic Press.
引用
收藏
页码:74 / 79
页数:6
相关论文
共 33 条
[1]  
Announcements, 1989, Gynecologic Oncology, V35, P125, DOI [DOI 10.1016/0090-8258(89)90027-9, 10.1016/0090-8258(89)90027-9]
[2]  
ANTONIADES J, 1976, CANCER, V38, P1838, DOI 10.1002/1097-0142(197610)38:4<1838::AID-CNCR2820380462>3.0.CO
[3]  
2-8
[4]   PROGNOSIS AND TREATMENT OF ENDOMETRIAL CANCER [J].
BERMAN, ML ;
BALLON, SC ;
LAGASSE, LD ;
WATRING, WG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1980, 136 (05) :679-688
[5]  
BORONOW RC, 1984, OBSTET GYNECOL, V63, P825
[6]   STAGE-III ADENOCARCINOMA OF THE ENDOMETRIUM - 2 PROGNOSTIC GROUPS [J].
BRUCKMAN, JE ;
BLOOMER, WD ;
MARCK, A ;
EHRMANN, RL ;
KNAPP, RC .
GYNECOLOGIC ONCOLOGY, 1980, 9 (01) :12-17
[7]  
COX DR, 1972, J R STAT SOC B, V34, P187
[8]  
CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
[9]  
2-8
[10]  
CREASMAN WT, 1981, AM J OBSTET GYNECOL, V141, P921